ScoreWhy is Shukra Pharmaceuticals Ltd ?
1
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.05 times
2
Healthy long term growth as Net Sales has grown by an annual rate of 42.12% and Operating profit at 101.99%
3
With a growth in Operating Profit of 2066.67%, the company declared Outstanding results in Dec 25
- NET SALES(Q) Highest at Rs 39.13 cr
- PBDIT(Q) Highest at Rs 27.13 cr.
- OPERATING PROFIT TO NET SALES(Q) Highest at 69.33%
4
With ROE of 44.3, it has a Very Expensive valuation with a 29.7 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 102.91%, its profits have risen by 256.5% ; the PEG ratio of the company is 0.3
5
Despite the size of the company, domestic mutual funds hold only 0% of the company
- Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
6
Consistent Returns over the last 3 years
- Along with generating 102.91% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Shukra Pharma. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Shukra Pharma. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Shukra Pharma.
102.91%
2.00
51.40%
Sensex
7.97%
0.69
11.53%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
42.12%
EBIT Growth (5y)
101.99%
EBIT to Interest (avg)
10.33
Debt to EBITDA (avg)
0.66
Net Debt to Equity (avg)
-0.15
Sales to Capital Employed (avg)
0.85
Tax Ratio
18.93%
Dividend Payout Ratio
4.57%
Pledged Shares
0
Institutional Holding
0.11%
ROCE (avg)
11.39%
ROE (avg)
14.72%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
67
Industry P/E
32
Price to Book Value
29.66
EV to EBIT
60.75
EV to EBITDA
54.94
EV to Capital Employed
34.55
EV to Sales
30.50
PEG Ratio
0.26
Dividend Yield
0.02%
ROCE (Latest)
15.87%
ROE (Latest)
44.31%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend37What is working for the Company
NET SALES(Q)
Highest at Rs 39.13 cr
PBDIT(Q)
Highest at Rs 27.13 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 69.33%
PBT LESS OI(Q)
Highest at Rs 26.01 cr.
PAT(Q)
Highest at Rs 20.36 cr.
EPS(Q)
Highest at Rs 0.46
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Shukra Pharma.
Net Sales - Quarterly
At Rs 39.13 cr has Grown at 345.7% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 8.78 CrMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 26.01 cr has Grown at 1212.0% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 1.98 CrMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 20.36 cr has Grown at 580.9% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 2.99 CrMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Quarterly
Highest at Rs 39.13 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 27.13 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 69.33%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 26.01 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 20.36 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 0.46
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
